Brain natriuretic peptide is a potent vasodilator in aged human microcirculation and shows a blunted response in heart failure patients

Journal of Geriatric Cardiology

Volumn 11, Issue 1, 2014, Pages 50-56

  Edvinsson, Marie Louise ^a   Uddman, Erik ^a   Edvinsson, Lars ^a   Andersson, Sven E ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Acetylcholine, brain natriuretic peptide; Cutaneous microcirculation; Endothelial responses; Heart failure; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SPIRONOLACTONE; WARFARIN;

AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOREARM; HEATING; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; REDUCTION; SIGNAL TRANSDUCTION; SKIN BLOOD FLOW; TREATMENT RESPONSE; VASODILATATION;

EID: 84902267895     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2014.01.004     Document Type: Article

References (18)

1. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240-e319.
2. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010; 303: 2141-2147.
3. Motiwala SR, Januzzi JL Jr. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Clin Pharmaco Ther 2013; 93: 57-67.
4. Andersson SE, Edvinsson ML, Björk J, et al. High NT-proBNP is a strong predictor of outcome in elderly heart failure patients. Am J Geriatr Cardiol 2008;17: 13-20.
5. Edvinsson ML, Uddman E, Andersson SE. Deteriorated function of cutaneous microcirculation in chronic congestive heart failure. J Geriatr Cardiol 2011;8: 82-87.
6. Andersson SE, Edvinsson ML, Edvinsson L. Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci (Lond) 2003;105: 699-707. (Pubitemid 38002361)
7. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
8. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000; 343: 246-253. (Pubitemid 30490392)
9. Committee for the VMAC investigators. Intravenous nesiritide verses nitroglycerine for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002; 287: 1531-1540.
10. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophospate-dependent signaling functions. Endocrine Rev 2006; 27: 47-72. (Pubitemid 43228238)
11. Edvinsson L, Andersson SE. Commentary on viewpoint: the human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 2008; 105: 381; author reply: 389.
12. Grubb A, Nyman U, Björk J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51: 1420-1431. (Pubitemid 41060874)
13. Kuhn M, Voss M, Mitko D, et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 2004; 64: 308-314. (Pubitemid 39361692)
14. Houben AJHM, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fund Clin Pharmacol 2005; 19: 411-419. (Pubitemid 41002410)
15. Dreyfuss C, Wauters A, Adamopoulos D, et al. L-NAME iontophoresis: A tool to assess NO-mediated vasoreactivity during thermal hyperaemic vasodilation in humans. J Cardiovas Pharmacol 2013; 61: 361-368.
16. Lund LH, Benson L, Dahlström U, et al. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 2012; 308: 2108-2117.
17. Lund LH, Jurga J, Edner M, et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J 2013; 34: 529-539.
18. Andersson SE, Edvinsson ML, Edvinsson L. Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity. Basic Clin Pharmacol Toxicol 2005; 97: 306-310. (Pubitemid 41608124)